• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病/非酒精性脂肪性肝炎的发展风险因素,包括遗传因素。

Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.

机构信息

Department of Internal Medicine, Northwell Health, 400 Community Drive, Manhasset, NY 11030, USA.

Department of Gastroenterology and Hepatology, Northwell Health, Center for Liver Diseases, 400 Community Drive, Manhasset, NY 11030, USA.

出版信息

Clin Liver Dis. 2018 Feb;22(1):39-57. doi: 10.1016/j.cld.2017.08.008. Epub 2017 Oct 6.

DOI:10.1016/j.cld.2017.08.008
PMID:29128060
Abstract

Nonalcoholic fatty liver disease is emerging as the most common cause of chronic liver disease worldwide. This trend is, in part, secondary, to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome. Other risk factors include age, gender, race/ethnicity, genetic predisposition, and polycystic ovarian disease. With the introduction of genome-wide association studies, genetic mutations contributing to inherited susceptibility to steatosis have been identified, which hold keys to future improvement in diagnosis and management. This article expands on the aforementioned risk factors and summarizes the current available data on genetic and environmental factors associated with this common entity.

摘要

非酒精性脂肪性肝病正在成为全球最常见的慢性肝病病因。这种趋势在一定程度上归因于肥胖症、2 型糖尿病和代谢综合征发病率的不断增加。其他危险因素包括年龄、性别、种族/民族、遗传易感性和多囊卵巢病。随着全基因组关联研究的引入,导致脂肪变性遗传易感性的基因突变已被确定,这为未来改善诊断和管理提供了关键。本文扩展了上述危险因素,并总结了与这种常见疾病相关的遗传和环境因素的现有数据。

相似文献

1
Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的发展风险因素,包括遗传因素。
Clin Liver Dis. 2018 Feb;22(1):39-57. doi: 10.1016/j.cld.2017.08.008. Epub 2017 Oct 6.
2
NAFLD-NASH: An Under-Recognized Epidemic.非酒精性脂肪性肝病-非酒精性脂肪性肝炎:一个未被充分认识的流行疾病。
Curr Vasc Pharmacol. 2018;16(3):209-213. doi: 10.2174/1570161115666170622074007.
3
The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.不同种族或族裔患者的非酒精性脂肪性肝病的流行率和发病机制。
Clin Liver Dis. 2016 May;20(2):215-24. doi: 10.1016/j.cld.2015.10.005. Epub 2016 Feb 17.
4
Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome.儿童和青少年非酒精性脂肪性肝病——与多囊卵巢综合征的关系
Curr Pharm Des. 2015;21(35):5144-50. doi: 10.2174/1381612821666150928105959.
5
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征。
Clin Liver Dis. 2018 Feb;22(1):133-140. doi: 10.1016/j.cld.2017.08.010. Epub 2017 Oct 21.
6
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.非酒精性脂肪性肝病或代谢相关脂肪性肝病诊断与心血管疾病:从流行病学到药物治疗方法。
Eur J Clin Invest. 2021 Jul;51(7):e13519. doi: 10.1111/eci.13519. Epub 2021 Mar 2.
7
Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update.非酒精性脂肪性肝病的遗传学:2018 年更新。
Curr Pharm Des. 2018;24(38):4566-4573. doi: 10.2174/1381612825666190119113836.
8
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?非酒精性脂肪性肝病与2型糖尿病:我们这个时代的肝脏疾病?
World J Gastroenterol. 2014 Jul 21;20(27):9072-89. doi: 10.3748/wjg.v20.i27.9072.
9
Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.遗传易感性与代谢功能障碍相关的脂肪性肝病和心血管结局:系统评价。
Eur J Clin Invest. 2020 Oct;50(10):e13331. doi: 10.1111/eci.13331. Epub 2020 Jul 13.
10
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.PNPLA3基因分型增加了非酒精性脂肪性肝病肥胖患者患非酒精性脂肪性肝炎的易感性。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1.

引用本文的文献

1
Broad-spectrum therapeutic potential of 4-phenylbutyrate in neurological and systemic diseases of viral and non-viral origin.4-苯基丁酸在病毒源性和非病毒源性神经及全身性疾病中的广谱治疗潜力。
Front Pharmacol. 2025 Aug 21;16:1621590. doi: 10.3389/fphar.2025.1621590. eCollection 2025.
2
Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease.体重波动与代谢功能障碍相关脂肪性肝病风险之间的关联。
World J Hepatol. 2025 May 27;17(5):103852. doi: 10.4254/wjh.v17.i5.103852.
3
Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis.
欧洲 HIV 感染者中 NAFLD 患病率和危险因素的地域差异:一项荟萃分析。
Front Public Health. 2024 Jan 4;11:1295165. doi: 10.3389/fpubh.2023.1295165. eCollection 2023.
4
Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China: A systematic review and meta-analysis.中国非肥胖/非酒精性脂肪性肝病的流行病学:系统评价和荟萃分析。
Saudi Med J. 2023 Sep;44(9):848-863. doi: 10.15537/smj.2023.44.9.20230021.
5
Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy.评估妊娠合并和不合并非酒精性脂肪性肝病母亲所生婴儿的 2 年结局。
Eur J Pediatr. 2023 Aug;182(8):3765-3774. doi: 10.1007/s00431-023-05044-7. Epub 2023 Jun 13.
6
Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study.加拿大初级保健中肥胖儿童非酒精性脂肪肝疾病的筛查模式:一项横断面研究。
Can J Gastroenterol Hepatol. 2022 Dec 24;2022:8435581. doi: 10.1155/2022/8435581. eCollection 2022.
7
Heightened levels of plasma growth differentiation factor 15 in men living with HIV.男性 HIV 感染者血浆生长分化因子 15 水平升高。
Physiol Rep. 2022 May;10(9):e15293. doi: 10.14814/phy2.15293.
8
Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance.糖尿病和酒精滥用与癌症的关联:分子机制和临床意义。
Cells. 2021 Nov 8;10(11):3077. doi: 10.3390/cells10113077.
9
Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers.HIV 阳性女性的肝脂肪变性变化与 BMI 相关,但与生物标志物无关。
Cytokine. 2021 Aug;144:155573. doi: 10.1016/j.cyto.2021.155573. Epub 2021 May 12.
10
Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications.非酒精性脂肪性肝病与内分泌疾病的关联:临床意义。
Can J Gastroenterol Hepatol. 2021 Jan 11;2021:6678142. doi: 10.1155/2021/6678142. eCollection 2021.